An interaction between CD200 and monoclonal antibody agonists to CD200R2 in development of dendritic cells that preferentially induce populations of CD4+CD25+ T regulatory cells

Journal of Immunology

Volumn 180, Issue 9, 2008, Pages 5946-5955

  Gorczynski, Reg ^a,b   Khatri, Ismat ^a   Lee, Lydia ^a   Boudakov, Ivo ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b MaRS Tower ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD200 ANTIGEN; CD200 RECEPTOR; CD200 RECEPTOR 2; CD200FC ANTIGEN; DOXYCYCLINE; GAMMA INTERFERON; LYMPHOCYTE ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD200R2; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIGENS, CD200; CD200 RECEPTOR, MOUSE; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CD4+ CD25+ T LYMPHOCYTE; CELL MATURATION; CELL POPULATION; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFECT; GENE DELETION; GENE OVEREXPRESSION; GRAFT INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; TRANSGENE; ALLOTRANSPLANTATION; ANIMAL; BAGG ALBINO MOUSE; DRUG POTENTIATION; GENETICS; IMMUNOLOGY; MOUSE MUTANT; SKIN TRANSPLANTATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; DENDRITIC CELLS; GENE DELETION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; SKIN TRANSPLANTATION; T-LYMPHOCYTES, REGULATORY; TOLL-LIKE RECEPTORS; TRANSGENES; TRANSPLANTATION, HOMOLOGOUS;

EID: 44449084462     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.9.5946     Document Type: Article

References (59)

1. Gorczynski, R., Z. Q. Chen, Y. Kai, L. Lee, S. Wong, and P. A. Marsden. 2004. CD200 is a ligand for all members of the CD200R family of immunoregulatory molecules. J. Immunol. 172: 7744-7749. (Pubitemid 38747642)
2. Wright, G. J., H. Cherwinski, M. Foster-Cuevas, G. Brooke, M. J. Puklavec, M. Bigler, Y. L. Song, M. Jenmalm, D. Gorman, T. McClanahan, et al. 2003. Characterization of the CD200 receptor family in mice and humans and their interactions with CD200. J. Immunol. 171: 3034-3046. (Pubitemid 37093527)
3. Hatherley, D., H. M. Cherwinski, M. Moshref, and A. N. Barclay. 2005. Recombinant CD200 protein does not bind activating proteins closely related to CD200 receptor. J. Immunol. 175: 2469-2474. (Pubitemid 41113857)
4. Gorczynski, R. M., M. S. Cattral, Z. G. Chen, J. A. Hu, J. Lei, W. P. Min, G. Yu, and J. Ni. 1999. An immunoadhesin incorporating the molecule OX-2 is a potent immunosuppressant that prolongs allo- and xenograft survival. J. Immunol. 163: 1654-1660.
5. Fallarino, F., C. Orabona, C. Vacca, R. Bianchi, S. Gizzi, C. Asselin-Paturel, M. C. Fioretti, G. Trinchieri, U. Grohmann, and P. Puccetti. 2005. Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells. Int. Immunol. 17: 1429-1438. (Pubitemid 41631319)
6. Copland, D. A., C. J. Calder, B. J. E. Raveney, L. B. Nicholson, J. Phillips, H. Cherwinski, M. Jenmalm, J. D. Sedgwick, and A. D. Dick. 2007. Monoclonal antibody-mediated CD200 receptor signaling suppresses macrophage activation and tissue damage in experimental autoimmune uveoretinitis. Am. J. Pathol. 171: 580-588. (Pubitemid 47344690)
7. Gorczynski, R. M., Z. Q. Chen, K. Yu, and J. Hu. 2001. CD200 immunoadhesin suppresses collagen-induced arthritis in mice. Clin. Immunol. 101: 328-334.
8. Gorczynski, R. M., Z. Q. Chen, Y. Kai, S. Wong, and L. Lee. 2004. Induction of tolerance-inducing antigen-presenting cells in bone marrow cultures in vitro using monoclonal antibodies to CD200R. Transplantation 77: 1138-1144. (Pubitemid 38580286)
9. Boudakov, I., P. Chang, and R. M. Gorczynski. 2005. Mechanisms involved in suppression induced by CD200:CD200R interaction. Recent Research Developments in Immunology, Vol. 7. S. G. Pandalai, ed. Research Signpost, Kerala, India, pp. 9-24.
10. Zhang, S. L., H. Cherwinski, J. D. Sedgwick, and J. H. Phillips. 2004. Molecular mechanisms of CD200 inhibition of mast cell activation. J. Immunol. 173: 6786-6793. (Pubitemid 39545181)
11. + Treg using monoclonal antibodies to CD200R. Transplantation 79: 488-491.
12. + versus acquired TR1 and TH3 regulatory T cells. Transplantation 77: S12-S15.
13. + regulatory T cell function. Eur. J. Immunol. 34: 2996-3005.
14. + T suppressor cells mediate tolerance to allogeneic heart transplants, inducing PIR-B in APC and rendering the graft invulnerable to rejection. Transpl. Immunol. 13: 239-247.
15. + regulatory T cells in allogeneic transplantation. Cytotherapy 7: 166-170.
16. Jaeckel, E., H. von Boehmer, and M. P. Manns. 2005. Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes. Diabetes 54: 306-310.
17. Wildin, R. S., and A. Freitas. 2005. IPEX and FOXP3: clinical and research perspectives. J. Autoimmun. 25: 56-62. (Pubitemid 41728046)
18. + regulatory T cells: current controversies and future perspectives. Eur. J. Immunol. 36: 2832-2836.
19. + regulatory T-cells in cancer. Immunol. Res. 32: 155-168.
20. Kronenberg, M. 2005. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23: 877-900. (Pubitemid 40563188)
21. Kapp, J. A., L. M. Kapp, and K. C. McKenna. 2004. γδ T cells play an essential role in several forms of tolerance. Immunol. Res. 29: 93-102. (Pubitemid 38822400)
22. Girardi, M. 2006. Immunosurveillance and immunoregulation by γδ T cells. J. Invest. Dermatol. 126: 25-31. (Pubitemid 43336090)
23. Chen, W., M. S. Ford, K. J. Young, and L. Zhang. 2003. Infusion of in vitro-generated DN T regulatory cells induces permanent cardiac allograft survival in mice. Transplant. Proc. 35: 2479-2480. (Pubitemid 37378037)
24. Sutmuller, R. P. M., M. E. Morgan, M. G. Netea, O. Grauer, and G. J. Adema. 2006. Toll-like receptors on regulatory T cells: expanding immune regulation. Trends Immunol. 27: 387-393. (Pubitemid 44038663)
25. + regulatory T cells. Proc. Natl. Acad. Sci. USA 103: 7048-7053.
26. Gorczynski, R. M., Y. Kai, and K. Miyake. 2006. MD1 expression regulates development of regulatory T cells. J. Immunol. 177: 1078-1084. (Pubitemid 44036610)
27. Grohmann, U., F. Fallarino, and P. Puccetti. 2003. Tolerance, DCs, and tryptophan: much ado about IDO. Trends Immunol. 24: 242-248. (Pubitemid 36555962)
28. Fallarino, F., C. Asselin-Paturel, C. Vacca, R. Bianchi, S. Gizzi, M. C. Fioretti, G. Trinchieri, U. Grohmann, and P. Puccetti. 2004. Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement. J. Immunol. 173: 3748-3754. (Pubitemid 39280736)
29. + Treg stimulated by anti-CD200R2 derived dendritic cells suppress MLCs and skin graft rejection. Transplantation 81: 1027-1034.
30. Boudakov, I., J. Liu, N. Fan, P. Gulay, K. Wong, and R. M. Gorczynski. 2007. Mice lacking CD200R1 show absence of suppression of lipopolysaccharide- induced tumor necrosis factor-α and mixed leukocyte culture responses by CD200. Transplantation 84: 251-257. (Pubitemid 47205760)
31. Yu, K., Z. Q. Chen, S. N. Wang, and R. Gorczynski. 2005. Decreased alloreactivity using donor cells from mice expressing a CD200 transgene under control of a tetracycline-inducible promoter. Transplantation 80: 394-401. (Pubitemid 41129969)
32. Freundlieb, S., C. Schirra-Muller, and H. Bujard. 1999. A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells. J. Gene Med. 1: 4-12. (Pubitemid 129631058)
33. Gorczynski, L., Z. Chen, J. Hu, G. Kai, V. Ramakrishna, and R. M. Gorczynski. 1999. Evidence that an OX-2 positive cell can inhibit the stimulation of type-1 cytokine production by bone-marrow-derived B7-1 (and B7-2) positive dendritic cells. J. Immunol. 162: 774-781. (Pubitemid 29035399)
34. + Treg is in part responsible for altered cytokine production by cells of aged mice which follows injection with a fetal liver extract. Immunol. Lett. 109: 101-112.
35. Gorczynski, R. M., C. P. Gorczynski, L. Y. Gorczynski, J. Hu, J. Lu, J. Manuel, and L. Lee. 2005. Neutral buoyancy and sleep-deprived serum factors alter expression of cytokines regulating osteogenesis. Acta Astronaut. 56: 890-899.
36. Lee, L., J. Liu, J. Manuel, and R. M. Gorczynski. 2006. A role for the immunomodulatory molecules CD200 and CD200R in regulating bone formation. Immunol. Lett. 105: 150-158. (Pubitemid 43816086)
37. Munz, C., R. M. Steinman, and S. I. Fujii. 2005. Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity. J. Exp. Med. 202: 203-207. (Pubitemid 41043815)
38. Watts, C., R. Zaru, A. R. Prescott, R. P. Wallin, and M. A. West. 2007. Proximal effects of Toll-like receptor activation in dendritic cells. Curr. Opin. Immunol. 19: 73-78. (Pubitemid 46091739)
39. Gomez, J., F. E. Borras, R. Singh, P. Rajananthanan, N. English, S. C. Knight, and C. V. Navarrete. 2004. Differential up-regulation of HLA-DM, invariant chain, and CD83 on myeloid and plasmacytoid dendritic cells from peripheral blood. Tissue Antigens 63: 149-157. (Pubitemid 38125661)
40. Jin, Y., L. Fuller, G. Ciancio, G. W. Burke, A. G. Tzakis, C. Ricordi, J. Miller, and V. Esquenzai. 2004. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow. Hum. Immunol. 65: 93-103. (Pubitemid 38224135)
41. Rosenblum, M. D., E. Olasz, J. E. Woodliff, B. D. Johnson, M. C. Konkol, K. A. Gerber, R. J. Orentas, G. Sandford, and R. L. Truitt. 2004. CD200 is a novel p53-target gene involved in apoptosis-associated immune tolerance. Blood 103: 2691-2698. (Pubitemid 38393026)
42. Ferguson, T. A., and H. Kazama. 2005. Signals from dying cells: tolerance induction by the dendritic cell. Immunol. Res. 32: 99-108. (Pubitemid 41153617)
43. Orabona, C., P. Puccetti, C. Vacca, S. Bicciato, A. Luchini, F. Fallarino, R. Bianchi, E. Velardi, K. Perruccio, A. Velardi, et al. 2006. Toward the identification of a tolerogenic signature in IDO-competent dendritic cells. Blood 107: 2846-2854.
44. Coates, P. T. H., F. J. Duncan, B. L. Colvin, Z. L. Wang, A. F. Zahorchak, W. J. Shufesky, A. E. Morelli, and A. W. Thomson. 2004. In vivo-mobilized kidney dendritic cells are functionally immature, subvert alloreactive T-cell responses, and prolong organ allograft survival. Transplantation 77: 1080-1089. (Pubitemid 38508927)
45. Tiao, M. M., L. Lu, R. Tao, L. Wang, J. J. Fung, and S. G. Qian. 2005. Prolongation of cardiac allograft survival by systemic administration of immature recipient dendritic cells deficient in NF-κB activity. Ann. Surg. 241: 497-505. (Pubitemid 40299728)
46. Rutella, S., S. Danese, and G. Leone. 2006. Tolerogenic dendritic cells: cytokine modulation comes of age. Blood 108: 1435-1440. (Pubitemid 44316106)
47. DePaz, H. A., O. O. Oluwole, A. O. Adeyeri, P. Witkowski, M. X. Jin, M. A. Hardy, and S. F. Oluwole. 2003. Immature rat myeloid dendritic cells generated in low-dose granulocyte macrophage-colony stimulating factor prolong donor-specific rat cardiac allograft survival. Transplantation 75: 521-528. (Pubitemid 36241150)
48. Kubo, T., R. D. Hatton, J. Oliver, X. F. Liu, C. O. Elson, and C. T. Weaver. 2004. Regulatory T cell suppression and anergy are differentially regulated by proin-flammatory cytokines produced by TLR-activated dendritic cells. J. Immunol. 173: 7249-7258. (Pubitemid 39628161)
49. Tan, J. K. H., and H. C. ONeill. 2005. Maturation requirements for dendritic cells in T cell stimulation leading to tolerance versus immunity. J. Leukocyte Biol. 78: 319-324. (Pubitemid 41061304)
50. Kadowaki, N., S. Ho, S. Antonenko, R. D. Malefyt, R. A. Kastelein, F. Bazan, and Y. J. Liu. 2001. Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194: 863-869. (Pubitemid 32983021)
51. - dendritic cell equivalents in fms-like tyrosine kinase 3 ligand bone marrow cultures. J. Immunol. 174: 6592-6597.
52. Uchijima, M., T. Nagata, T. Aoshi, and Y. Koide. 2005. IFN-γ overcomes low responsiveness of myeloid dendritic cells to CpG DNA. Immunol. Cell Biol. 83: 92-95. (Pubitemid 40179406)
53. Vicari, A. P., C. Chiodoni, C. Vaure, S. Ait-Yahia, C. Dercamp, F. Matsos, O. Reynard, C. Taverne, P. Merle, M. P. Colombo, et al. 2002. Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody. J. Exp. Med. 196: 541-549.
54. Warger, T., P. Osterloh, G. Rechtsteiner, M. Fassbender, V. Heib, B. Schmid, E. Schmitt, H. Schild, and M. P. Radsak. 2006. Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo. Blood 108: 544-550. (Pubitemid 44061354)
55. Waldner, H., M. Collins, and V. K. Kuchroo. 2004. Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease. J. Clin. Invest. 113: 990-997. (Pubitemid 38544120)
56. Okano, F., M. Miriam, K. Furumoto, and E. G. Engleman. 2005. In vivo manipulation of dendritic cells overcomes tolerance to unmodified tumor-associated self antigens and induces potent antitumor immunity. J. Immunol. 174: 2645-2652. (Pubitemid 40279678)
57. HamiltonWilliams, E. E., A. Lang, D. Benke, G. M. Davey, K. H. Wiesmuller, and C. Kurts. 2005. Cutting edge: TLR ligands are not sufficient to break cross-tolerance to self-antigens. J. Immunol. 174: 1159-1163.
58. Rozkova, D., R. Horvath, J. Bartunkova, and R. Spisek. 2006. Glucocorticoids severely impair differentiation and antigen presenting function of dendritic cells despite upregulation of Toll-like receptors. Clin. Immunol. 120: 260-271. (Pubitemid 44175897)
59. Gorczynski, R. M. 2001. Transplant tolerance modifying antibody, to CD200 receptor, but not CD200, alters cytokine production profile from stimulated macrophages. Eur. J. Immunol. 31: 2331-2337. (Pubitemid 32785351)